Home › Funds › SOFTBANK GROUP CORP. › RXRX

SOFTBANK GROUP CORP. position in RXRX

RECURSION PHARMACEUTICALCLASS A · Health Care

SOFTBANK GROUP CORP. reported holding 13,636,515 shares of RXRX (RECURSION PHARMACEUTICALCLASS A) in its Q2 2026 13F filing — a position valued at US$50.0M, representing 0.28% of its reported portfolio and ranking #15 among its reported holdings. SOFTBANK GROUP CORP. has disclosed RXRX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)13.64M sh
Reported value held$50.05M
Portfolio Weight0.28%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SOFTBANK GROUP CORP.'s RXRX position evolved

SOFTBANK GROUP CORP. first disclosed a stake in RXRX in Q4 2024 at 14,667,491 shares (US$99.2M). Across 7 filings, SOFTBANK GROUP CORP. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 13,636,515 shares valued at US$50.0M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 14.67M $99.15M New
Q1 2025 14.67M $77.59M Hold
Q2 2025 14.67M $74.22M Hold
Q3 2025 14.67M $71.58M Hold
Q4 2025 13.64M $55.77M Reduce
Q1 2026 13.64M $41.86M Hold
Q2 2026 13.64M $50.05M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RXRX and 13F data

RXRX (RECURSION PHARMACEUTICALCLASS A) is a Health Care company. 28 other funds we track also report a position in RXRX — the largest reported positions include ARK Invest (US$151.7M), MIC Capital Management UK LLP (US$35.4M), Data Collective IV GP, LLC (US$21.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RXRX

All RXRX fund holders →

FAQ

How long has SOFTBANK GROUP CORP. held RXRX?

SOFTBANK GROUP CORP. has disclosed RXRX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is SOFTBANK GROUP CORP.'s current position in RXRX?

As of Q2 2026, SOFTBANK GROUP CORP. holds 13.64M shares of RXRX (RECURSION PHARMACEUTICALCLASS A), valued at $50.05M, representing 0.28% of its reported portfolio and ranking #15.

Has SOFTBANK GROUP CORP. been buying or selling RXRX?

In the latest 13F filing (Q2 2026), SOFTBANK GROUP CORP. held unchanged its position in RXRX.

Which other funds hold RXRX?

Other major institutional holders of RXRX include ARK Invest, MIC Capital Management UK LLP, Data Collective IV GP, LLC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.